{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:05:37Z","timestamp":1772795137461,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T00:00:00Z","timestamp":1560124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Health Research Policy Research Programme","award":["027\/0089"],"award-info":[{"award-number":["027\/0089"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-4119-8","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T13:03:06Z","timestamp":1560171786000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["The impact of childhood pneumococcal vaccination on hospital admissions in England: a whole population observational study"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9092-3268","authenticated-orcid":false,"given":"Tinevimbo","family":"Shiri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noel D.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stavros","family":"Petrou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,10]]},"reference":[{"issue":"21","key":"4119_CR1","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1001\/jama.294.21.2712","volume":"294","author":"AM Fry","year":"2005","unstructured":"Fry AM, Shay DK, Holman RC, Curns AT, Anderson LJ. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA. 2005;294(21):2712\u20139.","journal-title":"JAMA"},{"issue":"1","key":"4119_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.arr.2003.07.002","volume":"3","author":"KC Meyer","year":"2004","unstructured":"Meyer KC. Lung infections and aging. Ageing Res Rev. 2004;3(1):55\u201367.","journal-title":"Ageing Res Rev"},{"issue":"3","key":"4119_CR3","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1097\/INF.0b013e3182784b26","volume":"32","author":"SA Madhi","year":"2013","unstructured":"Madhi SA, De Wals P, Grijalva CG, Grimwood K, Grossman R, Ishiwada N, et al. The burden of childhood pneumonia in the developed world: a review of the literature. Pediatr Infect Dis J. 2013;32(3):e119\u201327.","journal-title":"Pediatr Infect Dis J"},{"issue":"9","key":"4119_CR4","doi-asserted-by":"publisher","first-page":"e1001517","DOI":"10.1371\/journal.pmed.1001517","volume":"10","author":"DR Feikin","year":"2013","unstructured":"Feikin DR, Kagucia EW, Loo JD, Link-Gelles R, Puhan MA, Cherian T, et al. Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites. PLoS Med. 2013;10(9):e1001517.","journal-title":"PLoS Med"},{"issue":"20","key":"4119_CR5","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1056\/NEJMoa1401914","volume":"371","author":"A von Gottberg","year":"2014","unstructured":"von Gottberg A, de Gouveia L, Tempia S, Quan V, Meiring S, von Mollendorf C, et al. Effects of vaccination on invasive pneumococcal disease in South Africa. N Engl J Med. 2014;371(20):1889\u201399.","journal-title":"N Engl J Med"},{"issue":"1","key":"4119_CR6","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","volume":"201","author":"T Pilishvili","year":"2010","unstructured":"Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201(1):32\u201341.","journal-title":"J Infect Dis"},{"issue":"2","key":"4119_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/INF.0b013e3181f4cf69","volume":"30","author":"C Levy","year":"2011","unstructured":"Levy C, Varon E, Bingen E, L\u00e9cuyer A, Boucherat M, Cohen R. Pneumococcal meningitis in French children before and after the introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2011;30(2):168\u201370.","journal-title":"Pediatr Infect Dis J"},{"issue":"13","key":"4119_CR8","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.vaccine.2013.11.028","volume":"32","author":"P De Wals","year":"2014","unstructured":"De Wals P, Lefebvre B, Markowski F, Deceuninck G, Defay F, Douville-Fradet M, et al. Impact of 2+1 pneumococcal conjugate vaccine program in the province of Quebec, Canada. Vaccine. 2014;32(13):1501\u20136.","journal-title":"Vaccine"},{"issue":"7","key":"4119_CR9","doi-asserted-by":"publisher","first-page":"e0131494","DOI":"10.1371\/journal.pone.0131494","volume":"10","author":"FG Linden Mvd","year":"2015","unstructured":"Linden Mvd FG, Perniciaro S, Im\u00f6hl M. Effects of infant pneumococcal conjugate vaccination on serotype distribution in invasive pneumococcal disease among children and adults in Germany. PLoS One. 2015;10(7):e0131494.","journal-title":"PLoS One"},{"issue":"11","key":"4119_CR10","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.3201\/eid1811.120329","volume":"18","author":"AM van Deursen","year":"2012","unstructured":"van Deursen AM, van Mens SP, Sanders EA, Vlaminckx BJ, de Melker HE, Schouls LM, et al. Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerg Infect Dis. 2012;18(11):1729\u201337.","journal-title":"Emerg Infect Dis"},{"issue":"10","key":"4119_CR11","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","volume":"11","author":"E Miller","year":"2011","unstructured":"Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis. 2011;11(10):760\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"4119_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S1473-3099(18)30052-5","volume":"18","author":"SN Ladhani","year":"2018","unstructured":"Ladhani SN, Collins S, Djennad A, Sheppard CL, Borrow R, Fry NK, et al. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000\u201317: a prospective national observational cohort study. Lancet Infect Dis. 2018;18(4):441\u201351.","journal-title":"Lancet Infect Dis"},{"issue":"9807","key":"4119_CR13","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","volume":"378","author":"DM Weinberger","year":"2011","unstructured":"Weinberger DM, Malley R, Lipsitch M. Serotype replacement in disease following pneumococcal vaccination: A discussion of the evidence. Lancet. 2011;378(9807):1962\u201373.","journal-title":"Lancet"},{"issue":"6","key":"4119_CR14","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1473-3099(15)00030-4","volume":"15","author":"PA Waight","year":"2015","unstructured":"Waight PA, Andrews NJ, Ladhani NJ, Sheppard CL, Slack MP, Miller E. Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. Lancet Infect Dis. 2015;15(6):629.","journal-title":"Lancet Infect Dis"},{"issue":"27","key":"4119_CR15","first-page":"1","volume":"12","author":"PH England","year":"2018","unstructured":"England PH. Pneumococcal polysaccharide vaccine (PPV) coverage report, England, April 2017 to march 2018. Health Prot Rep. 2018;12(27):1\u20139.","journal-title":"Health Prot Rep"},{"issue":"6","key":"4119_CR16","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/thoraxjnl-2015-207688","volume":"71","author":"TP Quan","year":"2016","unstructured":"Quan TP, Fawcett NJ, Wrightson JM, Finney J, Wyllie D, Jeffery K, et al. Increasing burden of community-acquired pneumonia leading to hospitalisation, 1998-2014. Thorax. 2016;71(6):535\u201342.","journal-title":"Thorax"},{"issue":"5","key":"4119_CR17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.3201\/eid1405.071011","volume":"14","author":"CL Trotter","year":"2008","unstructured":"Trotter CL, Stuart JM, George R, Miller E. Increasing hospital admissions for pneumonia, England. Emerg Infect Dis. 2008;14(5):727\u201333.","journal-title":"Emerg Infect Dis"},{"key":"4119_CR18","volume-title":"The global burden of disease : 2004 update","author":"WHO","year":"2008","unstructured":"WHO. The global burden of disease : 2004 update. Geneva: World Health Organization; 2008."},{"issue":"5","key":"4119_CR19","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1056\/NEJMra1201534","volume":"369","author":"CJ Murray","year":"2013","unstructured":"Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448\u201357.","journal-title":"N Engl J Med"},{"issue":"10100","key":"4119_CR20","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(17)32367-X","volume":"390","author":"CJL Murray","year":"2017","unstructured":"Murray CJL, Lopez AD. Measuring global health: motivation and evolution of the global burden of disease study. Lancet. 2017;390(10100):1460\u20134.","journal-title":"Lancet"},{"issue":"5","key":"4119_CR21","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/S1473-3099(14)70027-1","volume":"14","author":"NG Martin","year":"2014","unstructured":"Martin NG, Sadarangani M, Pollard AJ, Goldacre MJ. Hospital admission rates for meningitis and septicaemia caused by Haemophilus influenzae, Neisseria meningitidis, and Streptococcus pneumoniae in children in England over five decades: a population-based observational study. Lancet Infect Dis. 2014;14(5):397\u2013405.","journal-title":"Lancet Infect Dis"},{"key":"4119_CR22","doi-asserted-by":"crossref","unstructured":"Oligbu G, Collins S, Djennad A, Sheppard CL, Fry NK, Andrews NJ, et al. Impact of pneumococcal conjugate vaccines on pneumococcal meningitis in England and Wales, 2000 - 2016. Paper presented at the 11th International Sympnosium on Pneumococci and Pneumococcal Diseases, Melbourne, Australia; April 15-19, 2018.","DOI":"10.1136\/archdischild-2018-rcpch.52"},{"issue":"3","key":"4119_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa0800836","volume":"360","author":"HE Hsu","year":"2009","unstructured":"Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, Craig AS, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360(3):244\u201356.","journal-title":"N Engl J Med"},{"issue":"31","key":"4119_CR24","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.1016\/j.vaccine.2009.04.057","volume":"27","author":"S Ruckinger","year":"2009","unstructured":"Ruckinger S, van der Linden M, Reinert RR, von Kries R, Burckhardt F, Siedler A. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany. Vaccine. 2009;27(31):4136\u201341.","journal-title":"Vaccine"},{"issue":"1","key":"4119_CR25","doi-asserted-by":"publisher","first-page":"e00309","DOI":"10.1128\/mBio.00309-10","volume":"2","author":"L Simonsen","year":"2011","unstructured":"Simonsen L, Taylor RJ, Young-Xu Y, Haber M, May L, Klugman KP. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio. 2011;2(1):e00309\u201310.","journal-title":"MBio"},{"issue":"9","key":"4119_CR26","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1136\/thx.2010.137802","volume":"65","author":"E Koshy","year":"2010","unstructured":"Koshy E, Murray J, Bottle A, Sharland M, Saxena S. Impact of the seven-valent pneumococcal conjugate vaccination (PCV7) programme on childhood hospital admissions for bacterial pneumonia and empyema in England: national time-trends study, 1997-2008. Thorax. 2010;65(9):770\u20134.","journal-title":"Thorax"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4119-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4119-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4119-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T04:24:20Z","timestamp":1663647860000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4119-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,10]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["4119"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4119-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,10]]},"assertion":[{"value":"8 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data were obtained in an anonymised format, and the study was not eligible for institutional ethical approval and participant consent. There were no administrative permissions required to access the raw data from the Hospital Episode Statistics (HES) database, as the data was provided by the Department of Health, England, (the custodian of the HES database) in an anonymised format.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"510"}}